广州微远基因科技有限公司, founded in 2018, operates in the Health Care industry, focusing on pathogen detection using advanced genomics and CRISPR technologies. Their slogan, "Pioneering Pathogen Detection with Advanced Genomics and Cutting-Edge CRISPR Technologies to Enhance Medical Precision and Accelerate Reporting Cycles," reflects their innovative approach to medical diagnostics. In their latest funding round, a Series D investment on May 16, 2024, they secured funding from Tianxin Fund and Kequan Fund. Based in Guangzhou, Guangdong, China, the company is positioned to make significant strides in advancing medical precision and reporting efficiency.
广州微远基因科技有限公司
Pioneering Pathogen Detection with Advanced Genomics and Cutting-Edge CRISPR Technologies to Enhance Medical Precision and Accelerate Reporting Cycles
Founded 2018
30 employees
Series D
Total: $630.00M
Health Care
General Information
Get notified when 广州微远基因科技有限公司 moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track 广州微远基因科技有限公司
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Health Care
About 广州微远基因科技有限公司
Taxonomy: Pathogen detection, Genomics, CRISPR, Medical precision, Infection treatment, High-throughput sequencing, Metagenomics, Nucleic acid enrichment, Clinical samples, Intelligent analysis, Reporting system, Medical diagnostics, Startup
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | •••••• | 2 | •••• •••• | 16 May 2024 |
| Series D | •••••• | 3 |
|
25 Nov 2021 |
| Series C | •••••• | 4 |
|
04 Feb 2021 |
| Series B | •••••• | 1 | •••• •••• | 12 Aug 2020 |
| Series A | •••••• | - | 11 Sep 2019 |
广州微远基因科技有限公司 Alternatives & Competitors
广州微远基因科技有限公司 vs
-logo.jpg "Harris County Medical Society (HCMS)"){kind=logo}
Harris County Medical Society (HCMS)
United States
14,000 + members and counting
40 employees
Health Care
广州微远基因科技有限公司 vs
-logo.jpg "Fort Defiance Industries (FDI)"){kind=logo}
Fort Defiance Industries (FDI)
United States
Field Medical Products and Services
19 employees
Design, Manufacturing
广州微远基因科技有限公司 vs
American Society of Transplant Surgeons
ExtremePACS
FAQ About 广州微远基因科技有限公司
Pioneering Pathogen Detection with Advanced Genomics and Cutting-Edge CRISPR Technologies to Enhance Medical Precision and Accelerate Reporting Cycles
广州微远基因科技有限公司 was founded in 2018.
广州微远基因科技有限公司 operates in the following industries: Health Care.
广州微远基因科技有限公司 has approximately 30 employees.
广州微远基因科技有限公司 has completed 5 funding rounds, raising a total of $630.00M. The latest funding stage is Series D.
Top alternatives and competitors to 广州微远基因科技有限公司 include Harris County Medical Society (HCMS), Fort Defiance Industries (FDI), OnSite Medical Service, American Society of Transplant Surgeons, Wells Johnson. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
广州微远基因科技有限公司 and Harris County Medical Society (HCMS) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors 广州微远基因科技有限公司 and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
